Pharmacology and Toxicology
-
Nucleotide Analogues as Inhibitors of Viral Polymerases
This article has 5 authors:Reviewed by ScreenIT
-
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
This article has 24 authors:Reviewed by ScreenIT
-
Discovery of rhodomyrtone as a broad-spectrum antiviral inhibitor with anti-SARS-CoV-2 activity
This article has 11 authors:Reviewed by ScreenIT
-
In Vitro Efficacy of “Essential Iodine Drops” Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2)
This article has 1 author:Reviewed by ScreenIT
-
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
This article has 49 authors:Reviewed by ScreenIT
-
Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening
This article has 9 authors:Reviewed by ScreenIT
-
CETSA ® MS profiling for a comparative assessment of FDA approved antivirals repurposed for COVID-19 therapy identifies Trip13 as a Remdesivir off-target
This article has 4 authors:Reviewed by ScreenIT
-
In Vitro Activity of Itraconazole Against SARS-CoV-2
This article has 11 authors:Reviewed by ScreenIT
-
The Effect of Famotidine on SARS-CoV-2 Proteases and Virus Replication
This article has 12 authors:Reviewed by ScreenIT
-
The hyperlipidaemic drug fenofibrate significantly reduces infection by SARS-CoV-2 in cell culture models
This article has 16 authors:Reviewed by ScreenIT